Onco-Innovations Revenue

Onco-Innovations had revenue of 154.67K CAD in the twelve months ending January 31, 2026. In the fiscal year ending April 30, 2025, Onco-Innovations had annual revenue of 65.29K.

Revenue (ttm)

154.67K

Revenue Growth

n/a

P/S Ratio

246.48

Revenue / Employee

n/a

Employees

n/a

Market Cap

38.12M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2025	65.29K	-	-
Apr 30, 2024	-	-	-
Apr 30, 2023	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Onco-Innovations News

9 days ago - Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing - Accesswire
9 days ago - Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010 - Accesswire
13 days ago - Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010 - Accesswire
14 days ago - NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development - GlobeNewsWire
15 days ago - Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes - GlobeNewsWire
16 days ago - Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010 - Accesswire
20 days ago - Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development - Accesswire
23 days ago - Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization - Accesswire

More News